| |
Diversity & Clinical Trials - Access & Trust
|
With Kimberly Tableman (CEO, Medicine X), Ramona Burress (Dir. Diversity & Inclusion In Clinical Trials, Johnson & Johnson), Eric Roberts (VP Trial Diversity & Inclusion, Hu), Sophia Goodison ( Scientist & Dir. Safety Evaluation & Risk Mgmt, GSK). |
| Venue, Online |
|
Jun 23 (Wed) , 2021 @ 12:00 PM
| |
FREE |
|
|
|
|
|
|
|
|
|
DETAILS |
|
Presented by Johnson & Johnson Innovation - JLABS & Newlab-a new limited event series focused on the topic of diversity, equity, & inclusion (DEI) in healthcare & clinical trials.
Join us on June 23rd at 12:00PM ET for part one of Diversity & Clinical Trials, Access & Trust. Our panel of speakers will investigate how recurring challenges in patient access to clinical trials affect study design, recruitment & retention, & diversity in data sets. What efforts should trial stakeholders explore to build trust & encourage buy-in into the trial process amongst diverse communities that are continually underrepresented?
|
|
|
|
|
|
|
|